OpGen, Inc. Gains 19.11%

Thu, Jul 29, 2021 at 05:33 PM

OpGen, Inc. (OPGN:NASDAQ) soared at $2.68, a gain of 19.1%. The stock got featured on our News Catalysts scanner on Wed, Jun 30, 2021 at 08:13 AM in the 'BIOTECH' category. From Wed, Jul 14, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Mon, Feb 08, 2021 at $4.37 with a volume of 88M+, and its share price has been moving sideways in recent weeks.

About OpGen, Inc. (OPGN:NASDAQ)

OpGen Inc is an precision medicine company using molecular diagnostics and bioinformatics to help combat infectious disease.

Top 10 Gainers:

Xenetic Biosciences, Inc. (XBIO:NASDAQ), 65.11%
Intec Pharma Ltd. (NTEC:NASDAQ), 48.09%
LendingClub Corporation (LC:NYSE), 47.82%
GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
Golden Star Resources Ltd. (GSS:NYSEMKT), 24.76%
MKTW (MKTW:NASDAQ), 23.13%
PRFX (PRFX:NASDAQ), 20.14%
OpGen, Inc. (OPGN:NASDAQ), 19.11%
BON (BON:NASDAQ), 16.99%
Iterum Therapeutics plc (ITRM:NASDAQ), 16.79%